• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail

Section Contents Menu

Vaccines

Telephone Conference Memorandum - 8/20/2007 - AFLURIA

TELEPHONE CONFERENCE MEMORANDUM

STN 125254/0:CTD BLA for Influenza Virus Vaccine
SPONSOR:CSL Limited
PRODUCT:Influenza Virus Vaccine
DATE:August 20, 2007

CBER REPRESENTATIVE:
Katherine Berkhousen

CSL REPRESENTATIVE:
Paul Hartman
Tel: 610-878-4644
Fax: 610-878-4182/4487

SUMMARY:

CSL contacted to address the following CMC analytical procedure concerns:

------------------------------------------------

  1. --------------------------------------------------------------------------------------------------------------------------------------
    --------------------------------------------------------------------------------------------------------------------------------------
    --------------------------------------------------------------------------------------------------------------------------------------
    --------------------------------------------------------------------------------------------------------------------------------------
    --------------------------------------------------------------------------------------------------------------------------------------
    --------------------------------------------------------------------------------------------------------------------------------------
    --------------------------------------------------------------------------------------------------------------------------------------
    --------------------------------------------------------------------------------------------------------------------------------------
  2. --------------------------------------------------------------------------------------------------------------------------------------
    --------------------------------------------------------------------------------------------------------------------------------------
    --------------------------------------------------------------------------------------------------------------------------------------
    ----------------------------------------------------
  3. --------------------------------------------------------------------------------------------------------------------------------------
    --------------------------------------------------------------------------------------------------------------------------------------
    --------------------------------------------------------------------------------------------------
  4. --------------------------------------------------------------------------------------------------------------------------------------
    ------------------------------------
    1. ------------------------------------------------------------------------------------------------------------------------
      ------------------------------------------------------------------------------------------------------------------------
      ------------------------------------------------------------------------------------------------------------------------
      -------------------------------------------------------------------------------------------------------------------

3


 

PAGE(S)


 

DETERMINED


 

TO BE


 

NOT RELEASABLE